PDF herunterladen
Thorac Cardiovasc Surg 1983; 31(6): 369-373
DOI: 10.1055/s-2007-1022021
© Georg Thieme Verlag Stuttgart · New York

Calcium Antagonists and Myocardial Protection: Diltiazem during Cardioplegic Arrest*

F. Yamamoto1 , A. S. Manning, M. V. Braimbridge, D. J. Hearse
  • The Heart Research Unit, The Rayne Institute, St. Thomas' Hospital, London, UK
  • 1Kleinwort Fellow, The Rayne Institute, St. Thomas' Hospital, London, UK
*This work was supported in part by grants from the British Heart Foundation and St. Thomas' Hospital Research Endowments Fund
Weitere Informationen

Publikationsverlauf

1983

Publikationsdatum:
19. März 2008 (online)

  als PDF herunterladen  Lizenzen und Reprints Alle Artikel dieser Rubrik

Summary

Using an isolated rat heart preparation as a model of cardiopulmonary bypass and ischemic arrest, the effects of the addition of the calcium antagonist, diltiazem, to St. Thomas' cardioplegic Solution were investigated. Under conditions of normothermic ischemic arrest (37 ° C, 35 min), the addition of diltiazem improved the protective properties of the St. Thomas' cardioplegic Solution. Moreover, studies with varying concentrations produced a bell-shaped dose-response curve for diltiazem with its optimal concentration at 0.5 μmoles/Iiter (0.21 mg/liter) when postischemic recovery of aortic flow was improved from 53.2 ± 4.3% to 79.2 ± 4.4% (p<0.01) and postischemic creatine kinase leakage was reduced by approximately 40%. Despite this marked additional protection when ischemic arrest was normothermic, diltiazem afforded no improvement in protection under conditions of hypothermic (20 °C, 180 min) ischemic arrest.

Key words

Calcium antagonists - Diltiazem - Cardioplegia - Myocardial protection - Hypothermie